Current assets decreased 42.6%
Current assets changed -42.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$10.4B→$6.0B4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →WDAY financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Noncurrent long-term debt decreased 33.3%
Noncurrent long-term debt changed -33.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$3.0B→$2.0B4 prior comparisons
Current ratio decreased 56.9%
Current ratio changed -56.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
2.1→0.914 prior comparisons
Working capital / assets moved 3422 bp lower
Working capital / assets changed -3422 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
30.41%→-3.81%4 prior comparisons
Current liabilities increased 32.9%
Current liabilities changed +32.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$4.9B→$6.6B4 prior comparisons
Working capital changed across a sign change
Working capital changed -111.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
$5.5B→-$604.0M4 prior comparisons
Total assets decreased 11.7%
Total assets changed -11.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$18.0B→$15.9B4 prior comparisons
Net income increased 177.2%
Net income changed +177.2% from the comparable as-filed period.
$228.0M→$632.0M2 prior comparisons
Free-cash-flow proxy decreased 21.8%
Free-cash-flow proxy changed -21.8% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$588.0M→$460.0M3 prior comparisons
Cash & equivalents decreased 47.7%
Cash & equivalents changed -47.7% from the comparable as-filed period.
$1.3B→$661.0M2 prior comparisons
Operating income increased 26.2%
Operating income changed +26.2% from the comparable as-filed period.
$248.0M→$313.0M2 prior comparisons
Operating cash flow decreased 15.7%
Operating cash flow changed -15.7% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$616.0M→$519.0M3 prior comparisons
Stockholders' equity decreased 29.6%
Stockholders' equity changed -29.6% from the comparable as-filed period.
$9.2B→$6.5B2 prior comparisons
Operating margin moved 125 bp higher
Operating margin changed +125 basis points from the comparable as-filed period.
10.56%→11.82%2 prior comparisons
Revenue increased 12.8%
Revenue changed +12.8% from the comparable as-filed period.
$2.3B→$2.6B2 prior comparisons
Capital expenditure increased 110.7%
Capital expenditure changed +110.7% from the comparable as-filed period.
$28.0M→$59.0M3 prior comparisons
Receivables / revenue moved 301 bp higher
Receivables / revenue changed +301 basis points from the comparable as-filed period.
68.53%→71.54%2 prior comparisons
Trade receivables increased 17.8%
Trade receivables changed +17.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$1.6B→$1.9B4 prior comparisons
Operating cash flow / net income decreased 69.6%
Operating cash flow / net income changed -69.6% from the comparable as-filed period.
2.7→0.822 prior comparisons
Capex / revenue moved 103 bp higher
Capex / revenue changed +103 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
1.19%→2.23%2 prior comparisons
Free-cash-flow margin moved 768 bp lower
Free-cash-flow margin changed -768 basis points from the comparable as-filed period.
25.04%→17.37%2 prior comparisons
Operating cash-flow margin moved 664 bp lower
Operating cash-flow margin changed -664 basis points from the comparable as-filed period.
26.24%→19.59%2 prior comparisons
Research & development increased 13.2%
Research & development changed +13.2% from the comparable as-filed period.
$660.0M→$747.0M2 prior comparisons
Stock-based compensation increased 18.2%
Stock-based compensation changed +18.2% from the comparable as-filed period.
$391.0M→$462.0M2 prior comparisons
SBC / revenue moved 79 bp higher
SBC / revenue changed +79 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
16.65%→17.44%2 prior comparisons
R&D / revenue moved 9 bp higher
R&D / revenue changed +9 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
28.11%→28.20%2 prior comparisons
Research & development increased 6.3%
Research & development changed +6.3% from the comparable as-filed period.
$663.0M→$705.0M0 prior comparisons
Capex / revenue increased by 1.54 points
Capex / revenue moved +1.54 percentage points from the comparable as-filed period.
1.61%→3.15%0 prior comparisons
Stock-based compensation decreased 10.9%
Stock-based compensation changed -10.9% from the comparable as-filed period.
$459.0M→$409.0M0 prior comparisons
Revenue increased 13.5%
Revenue changed +13.5% from the comparable as-filed period.
$2.2B→$2.5B0 prior comparisons
Operating margin increased by 11.56 points
Operating margin moved +11.56 percentage points from the comparable as-filed period.
1.74%→13.30%0 prior comparisons
Operating income increased 766.7%
Operating income changed +766.7% from the comparable as-filed period.
$39.0M→$338.0M0 prior comparisons
Operating cash flow increased 52.3%
Operating cash flow changed +52.3% from the comparable as-filed period.
$457.0M→$696.0M0 prior comparisons
Net income increased 226.5%
Net income changed +226.5% from the comparable as-filed period.
$68.0M→$222.0M0 prior comparisons
Free-cash-flow proxy increased 46.3%
Free-cash-flow proxy changed +46.3% from the comparable as-filed period.
$421.0M→$616.0M0 prior comparisons
Cash & equivalents decreased 42.5%
Cash & equivalents changed -42.5% from the comparable as-filed period.
$972.0M→$559.0M0 prior comparisons
Capital expenditure increased 122.2%
Capital expenditure changed +122.2% from the comparable as-filed period.
$36.0M→$80.0M0 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.